Cargando…

Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy

PURPOSE: To assess the clinical value of the pretherapeutic systemic inflammation score (SIS) in predicting the prognosis of hepatocellular carcinoma (HCC) after hepatic arterial infusion chemotherapy (HAIC). METHODS: From February 2016 to April 2021, 415 advanced HCC patients who underwent HAIC at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tianqing, Zheng, Zhikai, Wang, Jiongliang, He, Minrui, Wang, Juncheng, Pan, Yangxun, Chen, Jinbin, Hu, Dandan, Zhang, Yaojun, Xu, Li, Chen, Minshan, Zhou, Zhongguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697146/ http://dx.doi.org/10.2147/JHC.S437329

Ejemplares similares

Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy
por: Zheng, Zhikai, et al.
Publicado: (2023)

Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study
por: Wang, Jiongliang, et al.
Publicado: (2022)

Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma
por: Hu, Zili, et al.
Publicado: (2023)

Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma
por: Yang, Zhenyun, et al.
Publicado: (2023)

A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy
por: Zhang, Deyao, et al.
Publicado: (2022)

Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
por: Hu, Zili, et al.
Publicado: (2023)

Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery
por: Zhang, Deyao, et al.
Publicado: (2022)

Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma
por: Yang, Zhenyun, et al.
Publicado: (2023)

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation
por: Chen, Jinbin, et al.
Publicado: (2018)

A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
por: Zhang, Deyao, et al.
Publicado: (2022)

Development and validation of robust metabolism‐related gene signature in the prognostic prediction of hepatocellular carcinoma
por: Pan, Yangxun, et al.
Publicado: (2023)

A novel inflammation‐based nomogram system to predict survival of patients with hepatocellular carcinoma
por: Chen, Jinbin, et al.
Publicado: (2018)

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy
por: Sun, Xuqi, et al.
Publicado: (2020)

Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma
por: Yang, Zhenyun, et al.
Publicado: (2022)

Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
por: He, Ziming, et al.
Publicado: (2020)

Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis
por: Chen, Jinbin, et al.
Publicado: (2018)

Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score
por: Li, Yongjiang, et al.
Publicado: (2022)

Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
por: Sun, Xuqi, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Fu, Yizhen, et al.
Publicado: (2020)

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study
por: Zhang, Yaojun, et al.
Publicado: (2018)

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients
por: Chen, Jinbin, et al.
Publicado: (2017)

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma
por: Zhang, Yaojun, et al.
Publicado: (2017)

Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
por: Long, Teng, et al.
Publicado: (2023)

Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score
por: Zhao, Yang, et al.
Publicado: (2022)

Preoperative Versus Postoperative Transarterial Chemoembolization on Prognosis of Large Hepatocellular Carcinoma
por: Wang, Xiaohui, et al.
Publicado: (2021)

Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation
por: Hu, Zili, et al.
Publicado: (2022)

An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
por: Fu, Yizhen, et al.
Publicado: (2023)

Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization
por: ZHOU, DONGSHENG, et al.
Publicado: (2016)

High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis
por: Shakya, Manjul, et al.
Publicado: (2018)

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma
por: Zhou, Dongsheng, et al.
Publicado: (2015)

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)

The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer
por: Tatenuma, Tomoyuki, et al.
Publicado: (2019)

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
por: Liu, Furong, et al.
Publicado: (2012)

The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study
por: Huang, Chunyue, et al.
Publicado: (2023)

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials
por: Huang, YeXing, et al.
Publicado: (2022)

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?
por: Sun, Xuqi, et al.
Publicado: (2020)

Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy
por: Lai, Sicong, et al.
Publicado: (2020)

Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma
por: Wen, Yue-Feng, et al.
Publicado: (2017)

Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
por: Le Thiec, Maelle, et al.
Publicado: (2020)

Examining the blood amino acid status in pretherapeutic patients with hyperphenylalaninemia
por: Liang, Lili, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2v1b0jd9231upk1dohdmi0pqk6